Jeremy P. Springhorn, Chief Business Officer at Syros Pharmaceuticals, Inc. (SYRS), bought 30,121 shares at $4.97 ($150K) on 2019-11-12, disclosed to the SEC on 2019-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 9,879 | $49K | 32.9% |
| 2 | $4.97 | 10,121 | $50K | 33.6% |
| 3 | $4.97 | 10,121 | $50K | 33.6% |
| Total | $4.98 avg | 30,121 | $150K | 100% |
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |